Treatment options in Invasive Aspergillosis.
作者信息
Panackal Anil A, Bennett John E, Williamson Peter R
出版信息
Curr Treat Options Infect Dis. 2014 Sep;6(3):309-325. doi: 10.1007/s40506-014-0016-2.
Abstract
摘要
相似文献
1
Treatment options in Invasive Aspergillosis.侵袭性曲霉病的治疗选择
Curr Treat Options Infect Dis. 2014 Sep;6(3):309-325. doi: 10.1007/s40506-014-0016-2.
2
Current treatment options for invasive aspergillosis.侵袭性曲霉病的当前治疗选择。
Drugs Today (Barc). 2013 Mar;49(3):213-26. doi: 10.1358/dot.2013.49.3.1921234.
3
Is neutropenia still the main risk factor for invasive aspergillosis? A contemporary university hospital retrospective cohort of invasive aspergillosis in neutropenic and non-neutropenic patients.中性粒细胞减少症仍是侵袭性曲霉病的主要危险因素吗？一项当代大学医院对中性粒细胞减少和非中性粒细胞减少患者侵袭性曲霉病的回顾性队列研究。
Ann Clin Microbiol Antimicrob. 2025 Apr 25;24(1):28. doi: 10.1186/s12941-025-00794-8.
4
Invasive Aspergillosis in the Intensive Care Unit.重症监护病房中的侵袭性曲霉病
J Fungi (Basel). 2025 Jan 17;11(1):70. doi: 10.3390/jof11010070.
5
Preclinical Evaluation of Recombinant Microbial Glycoside Hydrolases in the Prevention of Experimental Invasive Aspergillosis.重组微生物糖苷水解酶在预防实验性侵袭性曲霉病中的临床前评价。
mBio. 2021 Oct 26;12(5):e0244621. doi: 10.1128/mBio.02446-21. Epub 2021 Sep 28.
6
Update on antifungal treatment of invasive Candida and Aspergillus infections.侵袭性念珠菌和曲霉感染的抗真菌治疗进展
Mycoses. 2004 Aug;47(7):263-76. doi: 10.1111/j.1439-0507.2004.01003.x.
7
Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.侵袭性曲霉病新型抗真菌和免疫调节策略综述
Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S157-87. doi: 10.1086/376523.
8
Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.伊曲康唑预防急性白血病中性粒细胞减少患者侵袭性牙龈曲霉病。
J Periodontol. 2002 Jan;73(1):33-8. doi: 10.1902/jop.2002.73.1.33.
9
Update on the treatment of chronic pulmonary aspergillosis.慢性肺曲霉病的治疗进展。
Curr Opin Infect Dis. 2023 Apr 1;36(2):146-151. doi: 10.1097/QCO.0000000000000913.
10
Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease.血液肿瘤患者侵袭性肺曲霉病诊断和治疗的循证临床标准
Braz J Infect Dis. 2025 Mar-Apr;29(2):104517. doi: 10.1016/j.bjid.2025.104517. Epub 2025 Feb 24.
引用本文的文献
1
ISCCM Position Statement on the Management of Invasive Fungal Infections in the Intensive Care Unit.国际重症监护医学学会关于重症监护病房侵袭性真菌感染管理的立场声明。
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S20-S41. doi: 10.5005/jp-journals-10071-24747. Epub 2024 Aug 10.
2
Uncovering the diversity of pathogenic invaders: insights into protozoa, fungi, and worm infections.揭示致病病原体的多样性：对原生动物、真菌和蠕虫感染的见解。
Front Microbiol. 2024 Mar 25;15:1374438. doi: 10.3389/fmicb.2024.1374438. eCollection 2024.
3
Update on therapeutic approaches for invasive fungal infections in adults.成人侵袭性真菌感染治疗方法的最新进展。
Ther Adv Infect Dis. 2024 Jan 20;11:20499361231224980. doi: 10.1177/20499361231224980. eCollection 2024 Jan-Dec.
4
Diagnosis of invasive fungal infections: challenges and recent developments.侵袭性真菌感染的诊断：挑战与新进展。
J Biomed Sci. 2023 Jun 19;30(1):42. doi: 10.1186/s12929-023-00926-2.
5
Post-COVID-19 Fungal Infection in the Aged Population.老年人群中的新冠后真菌感染
Vaccines (Basel). 2023 Feb 27;11(3):555. doi: 10.3390/vaccines11030555.
6
Targeting of phagolysosomes containing conidia of the fungus Aspergillus fumigatus with polymeric particles.用聚合颗粒靶向含有真菌烟曲霉分生孢子的吞噬体。
Appl Microbiol Biotechnol. 2023 Feb;107(2-3):819-834. doi: 10.1007/s00253-022-12287-1. Epub 2022 Dec 8.
7
Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments.眼内炎：流行病学、病理生物学及当前治疗方法
J Fungi (Basel). 2022 Jun 22;8(7):656. doi: 10.3390/jof8070656.
8
Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B.门诊患者的抗真菌治疗（OPAT）用于治疗侵袭性真菌感染，采用间断剂量的脂质体两性霉素 B。
Med Mycol. 2020 Oct 1;58(7):874-880. doi: 10.1093/mmy/myz134.
9
Novel Hit Compounds as Putative Antifungals: The Case of .新型作用靶标化合物抗真菌活性研究：.
Molecules. 2019 Oct 25;24(21):3853. doi: 10.3390/molecules24213853.
10
Intracranial Aspergillosis in an Immunocompetent Young Woman.一名免疫功能正常的年轻女性的颅内曲霉病。
Mycopathologia. 2017 Jun;182(5-6):527-538. doi: 10.1007/s11046-016-0106-4. Epub 2017 Jan 4.
本文引用的文献
1
Salvage combination antifungal therapy for acute invasive aspergillosis may improve outcomes: a systematic review and meta-analysis.挽救性联合抗真菌治疗急性侵袭性曲霉病可能改善预后：一项系统评价和荟萃分析。
Int J Infect Dis. 2014 Nov;28:80-94. doi: 10.1016/j.ijid.2014.07.007. Epub 2014 Sep 18.
2
The role of surgery in the treatment of invasive fungal infection in paediatric haematology patients: a retrospective single-centre survey.手术在儿科血液学患者侵袭性真菌感染治疗中的作用：一项回顾性单中心调查
Mycoses. 2014 Jul;57(7):394-9. doi: 10.1111/myc.12172. Epub 2014 Jan 19.
3
An immunomodulatory activity of micafungin in preclinical aspergillosis.米卡芬净在侵袭性曲霉病的临床前研究中的免疫调节活性。
J Antimicrob Chemother. 2014 Apr;69(4):1065-74. doi: 10.1093/jac/dkt457. Epub 2013 Nov 20.
4
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.两性霉素B去氧胆酸盐持续输注与传统输注的荟萃分析
PLoS One. 2013 Oct 21;8(10):e77075. doi: 10.1371/journal.pone.0077075. eCollection 2013.
5
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.两性霉素 B 和伏立康唑与棘白菌素联合治疗曲霉菌属：血清对抑制和杀菌相互作用的影响。
Antimicrob Agents Chemother. 2013 Oct;57(10):4656-63. doi: 10.1128/AAC.00597-13. Epub 2013 Jul 15.
6
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.半乳甘露聚糖检测和 PCR 与培养和组织学联合用于指导高危血液病患者侵袭性曲霉菌病的抗真菌治疗：一项随机对照试验。
Lancet Infect Dis. 2013 Jun;13(6):519-28. doi: 10.1016/S1473-3099(13)70076-8. Epub 2013 Apr 30.
7
Enhanced generation of reactive oxygen species by interferon-γ may have contributed to successful treatment of invasive pulmonary aspergillosis in a patient with chronic granulomatous disease.干扰素-γ增强活性氧的产生可能有助于慢性肉芽肿病患者侵袭性肺曲霉病的成功治疗。
Int J Hematol. 2013 Apr;97(4):505-10. doi: 10.1007/s12185-013-1315-y. Epub 2013 Mar 24.
8
The impact of azole resistance on aspergillosis guidelines.唑类耐药对曲霉病指南的影响。
Ann N Y Acad Sci. 2012 Dec;1272:15-22. doi: 10.1111/j.1749-6632.2012.06795.x.
9
Granulocyte macrophage colony-stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease.粒细胞巨噬细胞集落刺激因子在 66 例髓系或淋巴系肿瘤患者和造血干细胞移植后侵袭性真菌病患者中的应用。
Acta Haematol. 2013;129(1):26-34. doi: 10.1159/000342121. Epub 2012 Oct 2.
10
The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.PATH（抗真菌治疗前瞻性联盟）®登记处和侵袭性真菌感染：2012 年更新。
Diagn Microbiol Infect Dis. 2012 Aug;73(4):293-300. doi: 10.1016/j.diagmicrobio.2012.06.012.
Zotero 插件